Attention-deficit/hyperactivity disorder (adhd) as a noradrenergic disorder

作者: Joseph Biederman , Thomas Spencer , None

DOI: 10.1016/S0006-3223(99)00192-4

关键词: Central nervous systemNeuroimagingStimulantCognitionNeuroscienceAttention deficit hyperactivity disorderPsychologyArousalDopaminergicVigilance (psychology)Biological psychiatry

摘要: This review revisits the thesis that a dysregulation of central noradrenergic networks may underlie pathophysiology ADHD. We pertinent neurobiological and pharmacological literature on The system has been intimately associated with modulation higher cortical functions including attention, alertness, vigilance executive function. Noradrenergic activation is known to profoundly affect performance especially maintenance arousal, cognitive function be deficient in Data from family, adoption, twin, segregation analysis strongly support genetic hypothesis for this disorder. Although molecular studies ADHD are relatively new far definitive, several replicated reports have found associations between DAT D4 receptor genes. Brain imaging fit well idea dysfunction fronto-subcortical pathways occurs its underlying A wealth data (within without stimulant literature) provides strong evidence selective clinical activity drugs dopaminergic profiles. Available research compelling theoretic, basic biologic notion brain disorder likely etiology etiologic pathophysiologic heterogeneity. Neurobiological provide suggest play an important role therapeutics

参考文章(79)
Schroeder Dh, Parler Dw, Casat Cd, Pleasants Dz, Bupropion in children with attention deficit disorder. Psychopharmacology Bulletin. ,vol. 25, pp. 198- 201 ,(1989)
Pleasants Dz, Casat Cd, Van Wyck Fleet J, A double-blind trial of bupropion in children with attention deficit disorder. Psychopharmacology Bulletin. ,vol. 23, pp. 120- ,(1987)
Virkkunen M, Goldman D, Eggert M, Linnoila M, Rooney W, Malhotra Ak, The association between the dopamine D4 receptor (D4DR) 16 amino acid repeat polymorphism and novelty seeking. Molecular Psychiatry. ,vol. 1, pp. 388- ,(1996)
Lawrence M. Greenberg, Absalom M. Yellin, Carl Spring, Mary Metcalf, Clinical Effects of Imipramine and Methylphenidate in Hyperactive Children International Journal of Mental Health. ,vol. 4, pp. 144- 156 ,(1975) , 10.1080/00207411.1975.11448680
Leon Eisenberg, The Clinical Use of Stimulant Drugs in Children. Pediatrics. ,(1972)
Zoltan Molnar, G Bock, Development of the cerebral cortex J. Wiley. ,(1995)
Wigal Sb, Swanson Jm, Wigal T, King N, Glabe C, Kennedy Jl, LaHoste Gj, Dopamine D4 receptor gene polymorphism is associated with attention deficit hyperactivity disorder. Molecular Psychiatry. ,vol. 1, pp. 121- 124 ,(1996)
M D Krasowski, B L Leventhal, E H Cook, N J Cox, D M Olkon, M A Stein, J E Kieffer, Association of attention-deficit disorder and the dopamine transporter gene. American Journal of Human Genetics. ,vol. 56, pp. 993- 998 ,(1995)
Bupropion treatment of attention-deficit hyperactivity disorder in adults. American Journal of Psychiatry. ,vol. 147, pp. 1018- 1020 ,(1990) , 10.1176/AJP.147.8.1018